Figure 1.
Main renal biomarkers indicative of cardiorenal and renocardiac syndrome progression. NGAL: N-acetyl beta glucosaminidase. NAG: N-acetyl beta glucosaminidase. KIM 1: Kidney injury molecule. FABPs: Fat-ty acid-binding proteins; TIMP2 & IGFBP7: Tissue inhibitor of metalloproteinase 2 and insulin-like growth factor–binding protein 7.
